PathoNostics

PathoNostics is a Dutch molecular diagnostics company founded in 2011 in Maastricht. The company specializes in developing and commercializing real-time PCR kits for the rapid and accurate diagnosis of superficial and invasive fungal infections. PathoNostics is recognized for its multiplex real-time PCR assays that detect and differentiate fungal pathogens while identifying antifungal resistance markers, facilitating timely and targeted antifungal therapy. The company offers a range of CE-IVD-certified diagnostic products, including AsperGenius®, DermaGenius®, PneumoGenius®, MucorGenius®, and CandidaGenius®. These products are designed to deliver results within approximately three hours, ensuring high sensitivity, specificity, and accuracy. PathoNostics' technology combines real-time PCR with melting curve analysis, helping to avoid incorrect treatments and reduce healthcare costs. Their diagnostic kits are distributed globally, targeting clinical laboratories, hospitals, and healthcare providers to enhance patient outcomes through effective fungal infection detection.

• Employees10
• Founded2011